Lovely Meds Review

The plan table is the reason to read this page

Both compounded product pages open with a single figure introduced by the word From. On most sites that is where the disclosure stops, and the reader is left to discover at checkout that the number assumed a year of commitment. Here, a few hundred pixels down the same page, there is a table headed Plan Length and Price / Month with all four tiers in it: one month, three months, six months, twelve months, with the twelve-month row badged Best Value.

That table is what makes the hero figure honest rather than merely accurate. The From price is the twelve-month rate, and the page says so in a place a reader will actually reach. Our row carries the one-month tier, because that is the rate someone who does not want to commit for a year will pay, and it carries the twelve-month tier as a second row so the ladder is visible on our side too.

The same table settles the dose question in one line: all doses are the same price, and what changes with the tier is frequency of commitment, not strength. A reader titrating upward is not walking into a rising bill.

It sells the branded oral pill, and charges about twice what four others do

Foundayo is orforglipron — a once-daily tablet, FDA-approved, not a compounded preparation. Lovely Meds gives it a real product page with a real price on it, badged In stock, Rx, FDA-Approved and FSA/HSA eligible, with a line underneath stating that the figure reflects a one-month supply of medication. That is more than most sellers manage for any branded product, and it means a reader can compare without starting an intake.

The comparison is the interesting part. Alloy, ZipHealth, Sesame Care and Shapely all publish a price for the same branded pill, all four publish the same figure, and that figure is roughly half of what Lovely Meds asks. Those four were re-read on 5 and 6 September 2026 and this page on 6 September 2026, so this is a live spread between five current prices and not a stale number sitting beside a fresh one.

None of those five is quoting a different product. It is one manufacturer's tablet, and the gap between the cheapest and the most expensive route to it is wider than the gap between many compounded sellers on this roster. If the branded oral is what you want, this is the row to check the others against, not the row to buy from.

One caveat we can state and the page cannot: unlike the compounded pages, the Foundayo page publishes no plan ladder and no dose ladder. Sesame Care prints a six-step ladder for the same drug, in which the figure rises with the dose. Lovely Meds prints one number introduced by the words Starting at, and nothing on the page says what it starts from.

The FDA letter, and what the site says today

In September 2025 the FDA issued a warning letter to Lovely Meds, Inc. dba Lovely Meds. The subject was advertising, not manufacturing: the agency quoted two claims from the website — that the compounded products contained the same active ingredient as Wegovy and Ozempic, and as Zepbound and Mounjaro — and said those claims implied the compounded products were the same as an FDA-approved product when they are not, which misbrands them under the Federal Food, Drug, and Cosmetic Act.

We searched today's homepage and both compounded product pages for that phrase. It is not on any of the three. We did not read every page on the site, so what we can say is what we checked: the cited wording is gone from the three pages where a shopper would meet it.

What is on those pages now is close to the opposite: a standing line under the price stating that compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality. That is the disclosure the letter was asking for, in the place it needed to be.

This does not change the score or the position of this row, and it should not change your shortlist on its own. It is a fact about the company that a reader is entitled to have in front of them, and a reader who wants the full text can read the letter themselves.

Two legal documents, two different clinical groups

The Terms say Lovely Meds operates a technology platform, and that clinical evaluations and prescribing decisions are made independently by licensed healthcare providers affiliated with Beluga Health, P.A.

The privacy policy tells a different story. It says Lovely Meds, Inc. contracts with The Pharmacy Hub, describing it as an independent medical group that provides clinical telehealth services, and adds that Lovely Meds is also affiliated with Wasef Health, which supply medicinal products. So one document names Beluga Health as the clinical group and the other names two other companies, one of them in the same role.

Wasef Health is a name that turns up repeatedly in this comparison — Cora Health, Trava Health, Effecty, Gimme Care and Ondra Health all sit behind it — which is worth knowing if you were treating those sellers as independent second opinions. Lovely Meds is the one that names it in a document while naming a different group in another.

This is why the pharmacy question scores as unanswered here rather than answered. The Pharmacy Hub is a pharmacy; this site calls it a medical group. A name attached to the wrong role tells you less than a name attached to the right one, and the product page's own answer is the unhelpful one: prepared by state-licensed U.S. compounding pharmacies, plural and anonymous.

What you cannot find out before the intake

There is no list of the states this seller operates in. The FAQ acknowledges the question and then hands it back: availability depends on state regulations and clinician licensing, and the platform will tell you whether services are available in your state. The Terms add only that products are available where the provider group is authorized to operate. We read the homepage, both priced pages, the Foundayo page, the FAQ, the privacy policy and the Terms; there is no enumeration on any of them.

There is no named prescriber either. No medical director, no clinical lead, nobody with a name you could look up in a state licensing database before handing over your details. Cora Health and Midi Health both name theirs.

And there is no statement about a membership or program fee in either direction. We searched the two priced pages, the Foundayo page and the FAQ for the words membership and subscription. Neither word appears on any of them. That is not the same as no fee — it is silence, and our row records it as silence rather than as zero, because a zero would be a claim the site never makes.

A small thing, but it belongs here: the copyright line on the Terms reads 2025. In September 2026 that is a page nobody has revisited in a while, on a site whose regulator asked it to revisit its wording.